Loading this company
MetLife, Inc.
METPrices in USD
TickerWorth ScoreD29–57 of 100
What we think
Bank model: about $72.82 (range $62.79 to $86.67). Justified price-to-book, not a DCF.
Price
$101.18USD up +$1.60 (+1.61%)
Close of · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-20 05:45 UTC (15 hours ago).
Why did it move today?
Nothing we can cite explains today’s move for this company.
What our bank model says
Bank-model estimate
$72.82
Range $62.79 to $86.67, for a cost of equity ±1% (7.8%–9.8%)
Delayed price used by the model $99.58Prices are delayed.
Justified price-to-book, not a DCF. One formula’s estimate, not a price target.
Is it a good business?
- Valuation0 out of 100
- Growth83 out of 100
- Financial health67 out of 100
- Dividend100 out of 100
- Past performance83 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
$107.38 across 16 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. It operates in the Insurance - Life industry (Financial Services sector), headquartered in United States. The company employs roughly 46,000 people.
Key stats
52-week range$67.33–$102.43
- Open
- $100.25
- Day high
- $101.09
- Day low
- $99.53
- Previous close
- $100.76
- Volume
- 2,031,408 · 0.60× avg
- Average volume
- 3,382,484
- Market cap
- $63,280,795,648.00
- P/E (TTM)
- 19.08
- Earnings per share
- $5.22
- Beta
- 0.78
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Issued a public disclosure (Reg FD)
- Disclosed another material event
- Reported quarterly or annual results
- Issued a public disclosure (Reg FD)
- Reported shareholder vote results
- Disclosed another material event
- Reported quarterly or annual results
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro. See plans
- Johnson Jeh C.Grant / award · $51,326.40
- HUBBARD ROBERT GLENNGrant / award ·
Not investment advice. TickerWorth Score is a model output.